Hiroshi Aikata
Impact in
- Hepatology top 0.05%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Liver Disease and Transplantation
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
- Hepatology 227
- Hepatocellular Carcinoma Treatment and Prognosis 121
- Hepatitis C virus research 77
- Liver Disease and Transplantation 38
- Epidemiology 89
- Liver Disease Diagnosis and Treatment 57
- Hepatitis B Virus Studies 45
- Co-authors
- Kazuaki Chayama (208 shared papers)Michio Imamura (133 shared papers)Yoshiiku Kawakami (88 shared papers)Tomokazu Kawaoka (122 shared papers)Shoichi Takahashi (77 shared papers)Akira Hiramatsu (103 shared papers)Masataka Tsuge (100 shared papers)Clair Nelson Hayes (56 shared papers)
- Journals
- Hepatology Research (49 papers)Journal of Gastroenterology (28 papers)Journal of Gastroenterology and Hepatology (21 papers)Liver Cancer (13 papers)Oncology (13 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroshi Aikata
347 papers receiving 13.9k citations
Hiroshi Aikata's Hit Papers
Peers
Comparison fields: 5 of 148
- Hepatology 6.1k
- Cancer Research 2.9k
- Epidemiology 3.0k
- Oncology 1.7k
- Pathology and Forensic Medicine 1.2k
Countries citing papers authored by Hiroshi Aikata
This map shows the geographic impact of Hiroshi Aikata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Aikata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Aikata more than expected).
Fields of papers citing papers by Hiroshi Aikata
This network shows the impact of papers produced by Hiroshi Aikata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Aikata. The network helps show where Hiroshi Aikata may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroshi Aikata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 363 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 2 | Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer Hit paper breakdown → | 2016 | 574 |
| 3 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 550 |
| 4 | Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial Hit paper breakdown → | 2019 | 549 |
| 5 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 476 |
| 6 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 419 |
| 7 | Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial Hit paper breakdown → | 2023 | 313 |
| 8 | Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition Hit paper breakdown → | 2020 | 309 |
| 9 | 2020 | 293 | |
| 10 | Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations Hit paper breakdown → | 2018 | 286 |
| 11 | 2018 | 243 | |
| 12 | 2019 | 216 | |
| 13 | 2015 | 192 | |
| 14 | Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines) Hit paper breakdown → | 2023 | 192 |
| 15 | 2020 | 184 | |
| 16 | 2019 | 183 | |
| 17 | 2020 | 160 | |
| 18 | 2020 | 159 | |
| 19 | 2020 | 152 | |
| 20 | 2011 | 149 |
About Hiroshi Aikata
Hiroshi Aikata is a scholar working on Hepatology, Epidemiology, Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 363 papers that have together received 14.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (121 papers), Hepatitis C virus research (77 papers), Liver Disease Diagnosis and Treatment (57 papers), Hepatitis B Virus Studies (45 papers), Liver Disease and Transplantation (38 papers), Cancer Genomics and Diagnostics (15 papers), Genetic factors in colorectal cancer (11 papers) and HIV/AIDS drug development and treatment (10 papers). The work is most often cited by research in Hepatology (6.1k citations), Cancer Research (2.9k citations), Epidemiology (3.0k citations), Oncology (1.7k citations) and Pathology and Forensic Medicine (1.2k citations). Hiroshi Aikata has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kazuaki Chayama, Michio Imamura, Yoshiiku Kawakami, Tomokazu Kawaoka, Shoichi Takahashi, Akira Hiramatsu, Masataka Tsuge, Clair Nelson Hayes, Hidenori Ochi and Takashi Nakahara. Their work appears in journals such as Hepatology Research, Journal of Gastroenterology, Journal of Gastroenterology and Hepatology, Liver Cancer and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.